Related Experiment Video

Updated: Nov 29, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.7K

MiR-582-5p inhibits the growth and invasion of osteosarcoma cell by targeting NOVA1

C-Y Ye1, C-P Zheng, W-J Zhou

  • 1Department of Hematology, Wenzhou Central Hospital/Theorem Hospital Affiliated of Wenzhou Medical University, Wenzhou, China. wz_zhengcuiping@tom.com.

European Review for Medical and Pharmacological Sciences
|November 20, 2020
PubMed
Abstract

Insights

MicroRNA-582-5p (miR-582-5p) is downregulated in osteosarcoma (OS) and inhibits cancer cell growth. Targeting NOVA1, miR-582-5p suppresses OS progression, offering potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a primary bone malignancy with aggressive behavior.
  • Understanding the molecular mechanisms driving OS progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of microRNA-582-5p (miR-582-5p) in osteosarcoma (OS) cell behaviors.
  • To identify potential therapeutic targets for OS based on miR-582-5p function.

Main Methods:

  • Quantitative real-time PCR to measure miR-582-5p expression.
  • Cell counting kit-8, wound-healing, and Transwell invasion assays to assess cell proliferation, migration, and invasion.
  • Luciferase activity reporter assay and Western blotting to confirm the downstream target of miR-582-5p.

Main Results:

  • miR-582-5p expression was significantly downregulated in OS cell lines compared to normal cell lines.
  • Overexpression of miR-582-5p inhibited OS cell proliferation, migration, and invasion.
  • Neuro-oncological ventral antigen 1 (NOVA1) was identified as a direct target of miR-582-5p, and its overexpression counteracted the tumor-suppressive effects of miR-582-5p.

Conclusions:

  • miR-582-5p acts as a tumor suppressor in osteosarcoma by targeting NOVA1.
  • These findings elucidate the in vitro mechanisms of OS progression and suggest miR-582-5p as a potential therapeutic target.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.0K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

633

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K